Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

The ongoing evolution of Medical Affairs

April 14, 2023 | #COVID19, AI, Eddie Power, Healthcare Technology, Impetus Digital, Medical Affairs Pharma, Medical Affairs Teams, Natalie Yeadon, Pfizer, bioethics, blockchain, data privacy, machine learning, medical affairs, pharma technology, silico trials 

In the latest episode of Impetus Digital’s Fireside Chat series, Natalie Yeadon, Co-Founder and CEO of Impetus Digital talks to Eddie Power, Vice President of North America Medical Affairs, Hospital Business at Pfizer.They discuss a range of topics, including the effects of COVID-19 on the way Medical Affairs teams work and interact with the healthcare community. They also delve into the concept of ‘systems thinking’ and how this line of thinking can be applied within Medical Affairs and Pharma as a whole. Further, Eddie gives his thoughts on the role of technology in applying systems thinking, including barriers such as concerns about data privacy and bioethics. Other topics explored include innovative concepts such as in silico trials, AI and machine learning, and blockchain.

This content was provided by Impetus Digital

Company Details

- PMLiVE

Impetus Digital

Email
Website

 Latest Content from  Impetus Digital 

Improving Healthcare Access & Consumer Choice Through Digital Health

Erin Russell, Founder and CEO of Health Grizzly, shares her company’s approach to improving healthcare access and consumer choice through digital health. She also explores digital transformation in healthcare, how...

Improving Public Health Through Telemedicine

Laurence Girard, CEO of Fruit Street Health, shares his tips for aspiring HealthTech entrepreneurs, his views on the future of telemedicine and digital health, and why he thinks healthcare companies...

Social Media, Wearable Technologies, and AI

João Bocas, CEO, Keynote Speaker, Social Media Influencer & Advisor at Digital Salutem, shares his thoughts on several intriguing topics related to wearables, AI, machine learning, robotics, and other digital...

Advancing Human Health Through Precise Measures of Movement, Cognition, & Biometrics

Scott McMillan, CEO of XCO, discusses wearable technologies for chronic and acute disease monitoring, virtual trials, and assessment of athlete performance. Among other things, we also dive into the role...

Gamification for patient care, medical education, and virtual engagement

“Gamification”–adding game-like elements into non-game or real-world settings–has become a popular concept in the pharmaceutical, healthcare, and event industries. However, it is proving more than a mere buzzword. With diverse...

How to Simplify Genetics & Raise Awareness Around Orphan Diseases

Dr. Gail Ouellette, President and Scientific Director of Regroupement Québécois des Maladies Orphelines (RQMO)/Quebec Coalition of Orphan Diseases and Creator of the “Genetics Simply" website, shares her thoughts on the...

Exploring Digital Health From a Patient Perspective

Tjaša Zajc, MedsClub Community Developer and Communication Specialist at Better and the Founder & Host of the Faces of Digital Health podcast, explores international differences in the speed of digital...

InSite Events™ selected as an honorable mention in Fast Company’s 2021 World Changing Ideas Awards

From a cleaner freight train to an automated beehive, a way to recycle fabric, and other bold, new technologies, the 5th annual awards honor the products, concepts, companies, policies, and...

Nanobiotechnology, Artificial Intelligence, and Virtual Care

Venk Varadan, Co-founder & CEO at Nanowear, explores the use of cloth-based nanosensor technology, AI, and deep-learning-enabled diagnostics for remote monitoring of congestive heart failure, chronic diseases, and COVID-19. We...

Virtual Trials, Remote Care, & Cross-Border Collaboration: Ethical & Legal Challenges

Jennifer Cox, Manager, Research Contracts at Ottawa Hospital Research Institute (OHRI), dives into the legal challenges associated with virtual trials, remote monitoring, digitalized patient info, and cross-border collaborations in the...